Mercury Laboratories Ltd
₹0.00▲ +0.00 (+0.00%)
538964·NSE·Healthcare
Market Cap
96.90 Cr
PE Ratio
20.00
Volume
—
Day High - Low
—
52W High-Low
976.00 - 620.55
₹0.00▲ +0.00 (+0.00%)
Market Cap96.90 Cr
PE Ratio20.00
Volume—
Day High - Low—
52W High-Low976.00 - 620.55
Mercury Laboratories Ltd (538964): company summary
Mercury Laboratories Ltd (538964) is a micro-cap Healthcare company valued at ₹97 crore operating in Pharmaceuticals on the NSE and BSE.
Mercury Laboratories Ltd (538964) is a micro-cap Healthcare company valued at ₹97 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing slowly at 0.3% a year over three years; profit fell 3.7% a year, behind revenue — margins are under pressure. Return on equity is 9.2%.
- Valuation multiples
- The stock trades at 20.0 times earnings, a discount to the Healthcare median of 32.5, 1.67 times book value. It yields 0.4%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
3.9/10
Poor
Fair Value
Sign in to see
ROE
9.17%
Average
P/E
20.00x
Fair
Debt / Equity
0.14
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
52W₹620.55
₹976.00
DocStoX take
Supported by risk (6.5), but held back by growth (1.3). Scored on 4 of 5 measures.
DocStoX score
Medium confidence3.9
/10
Poor
Quality
Modest
ROE 9.2%
Valuation
Rich
P/E 20.0×
Growth
Flat
Revenue +2.0% 5Y CAGR
Risk
Moderate
D/E 0.14
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹97 Cr
52W High / Low
₹976 / ₹621
Dividend Yield
0.43%
Promoter Holding
73.66%
EPS (TTM)
₹26.17
Book Value
₹484.00
Key highlights
- Low leverage — D/E 0.14
- Profitable in all of the last 5 years
- Profit shrinking 1% a year
- Growth is weak (1.3/10)
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Mercury Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Mercury Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Mercury Laboratories Ltd with peers
Related tools & concepts
Value Mercury Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing